Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dronedarone for ventricular rate control in atrial fibrillation
NCT00697086Phase 3Completed
- Sponsor
- Sanofi
- Start
- Aug 2002
- Primary completion
- Jun 2004
- Modality
- Small Molecules
- Countries
- 9
01
Overview
A Phase 3 trial of dronedarone in Atrial fibrillation (AFib), sponsored by Sanofi. Started Aug 2002; status: completed.
02
Drugs
dronedarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00697086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00697086.